…t affected age group was 60–79 years (62%). Main therapies were chemotherapy (38%), immunotherapy (31%), biological therapy (21%), and other…
4articles mentioning treatments
4treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: immunotherapy-related ×
immunotherapy-related
This treatment is selected. Its supporting articles are shown below.
Articles mentioning immunotherapy-related
4 articles · page 1 of 1chemotherapyimmunotherapy-relatedimmunotherapybiological therapynivolumabpembrolizumabcarboplatinipilimumaboxaliplatinpaclitaxel+2 more
immunotherapy-relatedimmunotherapyPembrolizumabStanford UniversityUniversity of California San FranciscoUniversity of California DavisUniversity of PittsburghNSCLCmelanomaSutter Health
…entify early post-treatment changes potentially associated with immunotherapy-related cardiac effects.Methods Twenty-six healthy subjects underwent […
immunotherapyImmunotherapy-relatedcutaneous melanomabladder cancerlung cancersICIsimmune checkpoint inhibitors
… was identified as a strong prognostic factor, showing enhanced immunotherapy responses. However, in cancer patients received ICIs, a thresho…
immunotherapyimmunotherapy-relatedhepatocellular carcinomaHCCMinistry of Higher Education and ResearchFrench Data Protection Authority
…CC), with only 30% achieving complete pathological responses to immunotherapy. While transcriptomic profiling has identified HCC subgroups li…